waldenstroms.info – A BeiGene initiative
What is waldenstroms.info?
waldenstroms.info is a dedicated resource where healthcare providers (HCPs) can find up-to-date information on Waldenström’s macroglobulinemia (WM).
WM is a chronic, indolent, low-grade B-cell lymphoma characterized by bone marrow infiltration with lymphoplasmacytic cells and monoclonal IgM monoclonal gammopathy. Despite an indolent disease course, early diagnosis of WM is essential to treat symptoms and to avoid irreparable organ damage or fatal complications.
The aim of waldenstroms.info is to increase awareness and understanding of this rare disease to promote earlier diagnosis and the best possible standards of care for patients.
The home of up-to-date medical information on Waldenström’s macroglobulinemia.
What does waldenstroms.info offer?
On waldenstroms.info, HCPs can find educational medical information on WM symptoms, diagnosis and treatment options, and explore the latest expert insights into the disease. A dedicated patient support section provides HCPs with a list of patient support groups that may be useful for their patients.
Ongoing studies section
In the ongoing studies section, HCPs can learn more about the recent clinical trials in Waldenström’s macroglobulinemia, and the potential implications of emerging data for novel treatment strategies. The studies selected include phase II or III trials of targeted, chemotherapy-free agents:
Phase III Ibrutinib and Zanubrutinib
Phase III Ibrutinib
Phase II Acalabrutinib
Phase II Tirabrutinib
Phase II Venetoclax
Why does BeiGene support waldenstroms.info?
At BeiGene we are focused on serving our patients. Through the waldenstroms.info initiative, we aim to raise awareness about this rare disease and improve patient care by disseminating medical education to treating physicians.